News

Latest news

26th March 2026

AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass

10th March 2026

2月1日より、前Chordia社の森下大輔氏が弊社東京オフィスのメンバーとして加入いたしました

30th October 2025

Aboleris Pharma Appoints Seasoned Life-Sciences Executive Philippe Alen as Chief Business Officer

24th September 2025

EPICS Therapeutics Announces First Cohort Dosed with EP102 in First-In-Patient Oncology Trial and Securement of Additional Financing

14th August 2025

NBCと厚労省「創薬エコシステム発展支援事業」の委託契約を締結

14th August 2025

NBC and MHLW Sign Contract for Support Project for the Development of Drug Discovery Ecosystems

15th November 2024

Newton Biocapital announces its first investment in Japan from its “Newton Biocapital Partners II” fund to Japanese drug discovery startup, Tensegrity Pharma

14th November 2024

ニュートンバイオキャピタル、日本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、日本初の投資を発表

13th November 2024

French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance

1
2
3